Group 1 - Company Biostar Pharma, Inc. subscribed to LFM Stable Income Fund SP with an investment of $5 million, completed on November 28, 2024, and the investment is expected to mature on November 29, 2025 [1] - The company submitted a redemption request on January 21, 2025, but has not received a timely response regarding the redemption process [2] - Legal action is being pursued to expedite the redemption process, with Conyers Dill & Pearman LLP appointed as legal counsel to initiate liquidation proceedings for LFM Fund under Cayman Islands law [2] Group 2 - A petition was submitted to the Cayman Islands Grand Court on September 12, 2025, seeking the appointment of a liquidator for LFM Stable Income Fund SP, with a court hearing scheduled for November 19, 2025 [2] - If a liquidator is appointed, the current management will lose control of LFM Fund, and US-Biostar will become a creditor of the fund [2] - A statutory demand for repayment was issued to LFM Oversea Investment Limited, the sole shareholder of LFM Fund, requiring it to assume joint liability for the redemption under the subscription agreement [3]